TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
0
|
79
|
96 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-28
|
9
|
34 |
| EBITDA |
-28
|
9
|
34 |
| Total assets |
21
|
59
|
64 |
| Current assets |
21
|
59
|
64 |
| Current liabilities |
7
|
11
|
24 |
| Equity capital |
15
|
47
|
40 |
| - share capital |
13
|
14
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
71.4%
|
79.7%
|
62.5% |
| Turnover per employee |
0
|
79
|
96 |
| Profit as a percentage of turnover |
11.4%
|
35.4% | |
| Return on assets (ROA) |
-133.3%
|
15.3%
|
53.1% |
| Current ratio |
300%
|
536.4%
|
266.7% |
| Return on equity (ROE) |
-186.7%
|
19.1%
|
85.0% |
| Change turnover |
-72
|
-12
|
18 |
| Change turnover % |
-100%
|
-13%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.